Forbes contributors publish independent expert analyses and insights. Anisha Sircar is a journalist covering tech, finance and society. This voice experience is generated by AI. Learn more. This voice ...
Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has now introduced a pill version of its GLP-1 weight loss drug. Eli Lilly's ...
SAN FRANCISCO, Jan 12 (Reuters) - Eli Lilly's (LLY.N), opens new tab research and development head said on Monday the company will have plenty of supply to launch its much-anticipated new weight-loss ...
Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon with biology through artificial-intelligence-powered drug development. The ...
SAN FRANCISCO, Jan 12 (Reuters) - Nvidia (NVDA.O), opens new tab and U.S. pharma giant Eli Lilly (LLY.N), opens new tab will spend $1 billion building a new joint research lab in the San Francisco Bay ...
In an interview with Bloomberg News, Eli Lilly Chief Financial Officer Lucas Montarce said that the Indiana-based pharma giant remains on track for a potential FDA approval of its obesity pill, ...
Eli Lilly (LLY) is downgraded to Sell due to overstretched valuation and intensifying competition in the weight-loss drug market. LLY's heavy reliance on high-margin US sales from Zepbound and ...
Eli Lilly (LLY 1.51%) has behaved more like a tech stock in recent years than like a pharma stock. Tech players are known to soar in the double and triple digits when the environment and corporate ...
Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 ...
Ahead of her 80th birthday, Dolly Parton revisited her twangy 1977 ballad, “Light of a Clear Blue Morning,” with an impressive group of friends in a new video. The clip features Lainey Wilson, Miley ...
In 2026, new obesity pills will push the booming GLP-1 market into its next chapter. Pills may serve as a more convenient — and in certain cases cheaper — alternative to today's blockbuster injections ...
Hosted on MSN
Why Eli Lilly (LLY) stock is down today
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 4.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) delayed its decision on the company's new oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results